03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Rasilez HCT 150mg/25mg° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Novartis |
Responsible Party | Novartis Pharma AG |
Origin | Switzerland |
Manufacturer | Novartis Farma SPA |
Origin | Italy |
ATC | C09XA52 |
Revision Date | 01/10/2012 |
Rasilez HCT 150mg/25mg° :
Rasilez HCT 150mg/25mg° :
Rasilez HCT 150mg/25mg° :
Rasilez HCT 150mg/25mg° :
Rasilez HCT 150mg/25mg° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Rasilez HCT 150mg/25mg° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal discomfort | Rare |
Acute hepatic failure | Not known |
Acute kidney injury | Uncommon |
Agranulocytosis | Very rare |
Alkalosis hypochloraemic | Very rare |
Anaphylactic reactions | Rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Angle closure glaucoma | Not known |
Aplastic anemia | Not known |
Arrhythmia | Rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Not known |
Blood cholesterol increased | Very Common |
Blood creatinine increased | Rare |
Blood potassium increased | Not known |
Blood triglycerides increased | Very Common |
Bone marrow failure | Very rare |
Cholestasis | Rare |
Constipation | Rare |
Cough | Uncommon |
Cutaneous lupus erythematosus | Very rare |
Decreased appetite | Common |
Depression | Rare |
Diabetes mellitus | Rare |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
Dyspnoea (dyspnea) | Not known |
Erectile dysfunction | Common |
Erythema | Rare |
Erythema multiforme | Not known |
Glucosuria (Glycosuria) | Very rare |
Haematocrit decreased | Rare |
Haemoglobin decreased | Rare |
Haemolytic anemia | Very rare |
Headache | Rare |
Hepatic enzyme increased | Uncommon |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Not known |
Hypercalcaemia | Rare |
Hyperglycaemia | Rare |
Hyperkalaemia | Common |
Hypersensitivity | Rare |
Hyperuricaemia | Common |
Hypokalaemia | Very Common |
Hypomagnesaemia | Common |
Hyponatraemia (Hyponatremia) | Common |
Hypotension | Uncommon |
Jaundice | Rare |
Leucopenia (Leukopenia) | Very rare |
Lip swelling | Not known |
Liver disorder | Not known |
Lyell Syndrome (Toxic epidermal necrolysis) | Uncommon |
Muscle spasms | Not known |
Nausea | Common |
Necrotizing vasculitis | Very rare |
Oedema peripheral | Uncommon |
Oral disorder | Uncommon |
Orthostatic hypotension | Common |
Palpitations | Uncommon |
Pancreatitis | Very rare |
Paraesthesia (paresthesia) | Rare |
Pharyngeal oedema | Not known |
Photosensitivity reaction | Rare |
Pneumonitis | Very rare |
Pruritus | Uncommon |
Pulmonary oedema | Very rare |
Pyrexia | Not known |
Renal impairment | Uncommon |
Respiratory distress | Very rare |
Skin rash | Common |
Skin reaction | Uncommon |
Sleep disorder (Sleep disturbance) | Rare |
Stevens-Johnson syndrome | Uncommon |
Swelling face | Not known |
Swollen tongue | Not known |
Thrombocytopenia (Thrombopenia) | Rare |
Thrombocytopenic purpura | Rare |
Urticaria | Common |
Vertigo | Not known |
Visual disturbance | Rare |
Vomiting | Common |
Rasilez HCT 150mg/25mg° :
NB : Products With Same Indication |
Different Units By MoH Code
Rasilez HCT 150mg/25mg° MoH 5652 :
Form | Tablet, Film-Coated |
Package Size | Box of 28 |
Strength | 150mg/25mg |
Storage Condition | <30°C In the original container |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 218328/09 |
Submission date | 01/01/2009 |
Registration Year | 2010 |
Archived Date | 2017 |
Withdrawn Date | 04/05/2021 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 28 | |
● Public Price: | 41.5 CHF | ( 4,291,930.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,4821 CHF | ( 103,420.00 LBP ) |
● Exfactory Price: | 21.88 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 28 | |
● Public Price: | 32.35 EUR | ( 3,133,938.60 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 1,1554 EUR | ( 96,876.00 LBP ) |
● Pharmacy Price: | 25.35 EUR | ( 2455806.6 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 28's (7's Blister x 4) | |
● Public Price: | 112 AED | ( 2,706,032.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 90.1 AED | ( 2176906.1 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 28 | |
● Public Price: | 112 AED | ( 2,706,032.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 4 AED | ( 96,644.00 LBP ) |
● Pharmacy Price: | 90.1 AED | ( 2176906.1 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 28 | |
● Public Price: | 101.3 SAR | ( 2,394,732.00 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 3,6179 SAR | ( 70,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 98 | |
● Public Price: | 93.22 EUR | ( 9,030,780.72 LBP ) |
● Pack size unit used: | 98 | |
● Cost/Unit: | 0,9512 EUR | ( 0.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 22/06/2017 | |
● Type: | Medicine Non Marketed |
● Country: | Cyprus | |
● Package Size: | 28 TABS | |
● Public Price: | 24.26 EUR | ( 2,350,211.76 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,8664 EUR | ( 0.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 28 | |
● Public Price: | 20.15 EUR | ( 1,952,051.40 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,7196 EUR | ( 0.00 LBP ) |
● Exfactory Price: | 19 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File